Nausea occurs in 15-40% of patients initiating GLP-1 agonists, with vomiting, diarrhea, and abdominal discomfort also common, particularly during dose escalation
Psychiatry 86 , 811819 (2019)
To determine your specific co-pay, you can use your prescription or medical card and the Jardiance coverage and co-pay calculator
Last week, Kenlys compounding pharmacists informed her that, because tirzepatide was no longer on the shortage list, they would need to stop making the compounded versions or seek out a different supplier
Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) H 2 O : 50 mg/mL (Need ultrasonic) Purity & Documentation Data Sheet (292 KB) SDS (252 KB) English - EN (252 KB) Franais - FR (252 KB) Deutsch - DE (252 KB) Norwegian - NO (252 KB) Espaol - ES (252 KB) Swedish - SV (252 KB) Italian - IT (252 KB) Korean - KR (252 KB) Portuguese - PT (252 KB) Handling Instructions (2659 KB) References [1]
Understanding these differences is essential for patients considering tirzepatide treatment
